Using tumor organoids to guide treatment for rare cancer
Part of Cancer clinical trials.
This study is creating lab-grown mini-tumors (organoids) from your cancer to help doctors choose the best treatment for you. If you have a rare undifferentiated primary carcinoma, your tumor sample could be used to test different drugs before you receive them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a rare cancer called undifferentiated primary carcinoma (the cells don't look like they come from a specific organ).
- You are about to start, or have recently started, your first round of chemotherapy or other systemic treatment (no more than 2 cycles completed).
- Your doctors expect you to live at least 3 months.
- You are 18 years or older.
- You are not in a situation where your freedom is restricted or you are under legal guardianship.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses special lab models (“immune organoids”) to study certain cancers in children and young people. It may help researchers learn what those cancers do and improve future treatment ideas.
This study tests a new way to grow miniature versions of your brain tumor in the lab (called organoids) from a small piece of your tumor removed during surgery. The results may help doctors understand which treatments might work best for you in the future.
This study tests whether growing a patient's tumor cells in a dish (called an organoid) can help doctors choose the best next treatment. It is for people with advanced colorectal or pancreatic cancer who have run out of standard options.
This trial uses advanced testing (genetic sequencing and lab-grown tumor models) to find the best treatment for people with advanced solid tumors that haven't responded to at least one standard treatment. The goal is to personalize therapy based on your tumor's unique features.
This trial tests whether growing your tumor cells in a lab (organoids) can help pick the best drug for your advanced liver cancer. It aims to make treatment more personalized and effective.
This trial tests if growing a patient's tumor cells in the lab (organoids) and analyzing their genes can help doctors choose more effective treatments for rare cancers. You might be eligible if you have an advanced rare solid tumor and can provide fresh or stored tumor tissue for testing.
Hear when a new Undifferentiated Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.